Brain Cancer Research - Symptoms, Benign and Malignant Tumors, Gliomas, Treatment

Brain Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Cancer, including details on symptoms, benign and malignant tumors, gliomas, treatment.


Brain Cancer Research Today

Home

View Latest Issue

Information About Brain Cancer

Books on Brain Cancer

Advertising in Research Today

View Other Research Today Publications



Volume 2 (2005), Issue 9 (September)

  1. Current management of brain metastases, with a focus on systemic options.
    J Clin Oncol, 23(25): 6207-19. [Abstract] [Full-text]
  2. Etoposide, vincristine, and cyclosporin A with standard-dose radiation therapy in newly diagnosed diffuse intrinsic brainstem gliomas: a pediatric oncology group phase I study.
    Pediatr Blood Cancer, 45(5): 644-8. [Abstract] [Full-text]
  3. Patterns of treatment failure in infants with primitive neuroectodermal tumors who were treated on CCG-921: a phase III combined modality study.
    Pediatr Blood Cancer, 45(5): 676-82. [Abstract] [Full-text]
  4. Unilateral profound hearing loss and the effect on quality of life after cerebellopontine angle surgery.
    Otolaryngol Head Neck Surg, 133(3): 339-46. [Abstract] [Full-text]
  5. Cyclosporine a induces growth arrest or programmed cell death of human glioma cells.
    Neurochem Int, 47(6): 430-41. [Abstract] [Full-text]
  6. Cutaneous metastasis from glioblastoma.
    Br J Neurosurg, 19(1): 65-8. [Abstract] [Full-text]
  7. Spontaneous transdural spread of glioblastoma with atypical presentation.
    Br J Neurosurg, 19(1): 61-5. [Abstract] [Full-text]
  8. A spectrum of behaviour in silent corticotroph pituitary adenomas.
    Br J Neurosurg, 19(1): 38-42. [Abstract] [Full-text]
  9. Real-time functional magnetic resonance imaging (rt-fMRI) in patients with brain tumours: preliminary findings using motor and language paradigms.
    Br J Neurosurg, 19(1): 25-32. [Abstract] [Full-text]
  10. Absence of adrenocorticotropin (ACTH) neurosecretory dysfunction but increased cortisol concentrations and production rates in ACTH-replete adult cancer survivors after cranial irradiation for nonpituitary brain tumors.
    J Clin Endocrinol Metab, 90(9): 5217-25. [Abstract] [Full-text]
  11. Is there a role for ghrelin and peptide-YY in the pathogenesis of obesity in adults with acquired structural hypothalamic damage?
    J Clin Endocrinol Metab, 90(9): 5025-30. [Abstract] [Full-text]
  12. Detection of adrenocorticotropin-secreting pituitary adenomas by magnetic resonance imaging in children and adolescents with cushing disease.
    J Clin Endocrinol Metab, 90(9): 5134-40. [Abstract] [Full-text]
  13. Receptors and sites of synthesis and storage of gamma-aminobutyric acid in human pituitary glands and in growth hormone adenomas.
    Am J Clin Pathol, 124(4): 550-8. [Abstract] [Full-text]
  14. Survivin expression in intracranial ependymomas and its correlation with tumor cell proliferation and patient outcome.
    Am J Clin Pathol, 124(4): 543-9. [Abstract] [Full-text]
  15. Genetic alteration and expression of the phosphoinositol-3-kinase/Akt pathway genes PIK3CA and PIKE in human glioblastomas.
    Neuropathol Appl Neurobiol, 31(5): 486-90. [Abstract] [Full-text]
  16. Immunohistochemical estimation of cell cycle entry and phase distribution in astrocytomas: applications in diagnostic neuropathology.
    Neuropathol Appl Neurobiol, 31(5): 455-66. [Abstract] [Full-text]
  17. Clinicopathologic significance of cystatin C expression in gliomas.
    Hum Pathol, 36(9): 1008-15. [Abstract] [Full-text]
  18. Amplification of genes encoding KIT, PDGFRalpha and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme.
    J Pathol, 207(2): 224-31. [Abstract] [Full-text]
  19. Angiogenesis of glioma: evaluation of ultrastructural characteristics of microvessels and tubular bodies (Weibel-Palade) in endothelial cells and immunohistochemical findings with VEGF and p53 protein.
    Med Mol Morphol, 38(1): 36-42. [Abstract] [Full-text]
  20. Phenotype dependent differential effects of interleukin-1beta and amyloid-beta on viability and cholinergic phenotype of T17 neuroblastoma cells.
    Neurochem Int, 47(7): 466-73. [Abstract] [Full-text]
  21. Detection of intracellular lactate with localized diffusion {1H-13C}-spectroscopy in rat glioma in vivo.
    J Magn Reson, 177(1): 129-38. [Abstract] [Full-text]
  22. Inter-alu PCR detects high frequency of genetic alterations in glioma cells exposed to sub-lethal cisplatin.
    Int J Cancer, 117(4): 683-9. [Abstract] [Full-text]
  23. Autoantibodies against GLEA2 and PHF3 in glioblastoma: tumor-associated autoantibodies correlated with prolonged survival.
    Int J Cancer, 117(3): 456-9. [Abstract] [Full-text]
  24. Distribution, characterization and significance of polyomavirus genomic sequences in tumors of the brain and its covering.
    J Med Virol, 77(3): 447-54. [Abstract] [Full-text]
  25. hERG1 channels are overexpressed in glioblastoma multiforme and modulate VEGF secretion in glioblastoma cell lines.
    Br J Cancer, 93(7): 781-92. [Abstract] [Full-text]
  26. Perioperative management of patients undergoing transsphenoidal pituitary surgery.
    Anesth Analg, 101(4): 1170-81. [Abstract] [Full-text]
  27. Phase I trial of temozolomide plus O6-benzylguanine for patients with recurrent or progressive malignant glioma.
    J Clin Oncol, 23(28): 7178-87. [Abstract] [Full-text]
Place a permanent text-link or advertisement here.

© 2004-2012 Brain Cancer Research Today. All Rights Reserved.



Brain Cancer Research Today Archive:

Volume 1 (2004)
  Issue 1 (August)
  Issue 2 (September)
  Issue 3 (October)
  Issue 4 (November)
  Issue 5 (December)

Volume 2 (2005)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 3 (2006)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 4 (2007)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 5 (2008)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 6 (2009)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 7 (2010)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 8 (2011)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 9 (2012)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)



Brain Cancer Books

Trends in Brain Cancer Research (Horizons in Cancer Research)

Trends in Brain Cancer Research (Horizons in Cancer Research)